Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Mangia

Showing results (11-20 of 157) with videos related to

Pageof 16
Sort By:
Hepatology (Baltimore, Md.)|July 31, 2008
Short treatment to patients with genotype 2 or 3Olav Dalgard, Alessandra Mangia
The New England Journal of Medicine|October 19, 2007
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCVAngelo Andriulli, Alessandra Mangia
Hepatology (Baltimore, Md.)|June 26, 2009
Management of patients with hepatitis C virus genotype 2 or 3: comments on updated American Association for the Study of Liver Diseases practice guidelinesOlav Dalgard, Alessandra Mangia
Drugs|October 17, 2006
Short-term therapy for patients with hepatitis C virus genotype 2 or 3 infectionOlav Dalgard, Alessandra Mangia
Gut|December 17, 2009
Tailoring the length of antiviral treatment for hepatitis CAlessandra Mangia, Angelo Andriulli
Expert Review of Gastroenterology & Hepatology|November 7, 2019
Progress in promising anti-fibrotic therapiesRosanna Santoro, Alessandra Mangia
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 30, 2012
Futility of antiviral treatments for hepatitis C: an evolving concept entering the direct antiviral agents eraSavino Bruno, Alessandra Mangia
Seminars in Liver Disease|April 24, 2024
Adherence in Hepatitis C Virus Treatment: What We KnowSteven L Flamm, Alessandra Mangia
Cells|April 23, 2020
Noninvasive Diagnosis of NAFLD and NASHValeria Annarita Piazzolla, Alessandra Mangia
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 5, 2011
Chronic viral hepatitis: the histology reportMaria Guido, Alessandra Mangia, Gavino Faa, et al.
Pageof 16

Showing results (11-20 of 157) with videos related to

Sort By:
Pageof 16
Hepatology (Baltimore, Md.)|July 31, 2008
Short treatment to patients with genotype 2 or 3Olav Dalgard, Alessandra Mangia
The New England Journal of Medicine|October 19, 2007
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCVAngelo Andriulli, Alessandra Mangia
Hepatology (Baltimore, Md.)|June 26, 2009
Management of patients with hepatitis C virus genotype 2 or 3: comments on updated American Association for the Study of Liver Diseases practice guidelinesOlav Dalgard, Alessandra Mangia
Drugs|October 17, 2006
Short-term therapy for patients with hepatitis C virus genotype 2 or 3 infectionOlav Dalgard, Alessandra Mangia
Gut|December 17, 2009
Tailoring the length of antiviral treatment for hepatitis CAlessandra Mangia, Angelo Andriulli
Expert Review of Gastroenterology & Hepatology|November 7, 2019
Progress in promising anti-fibrotic therapiesRosanna Santoro, Alessandra Mangia
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 30, 2012
Futility of antiviral treatments for hepatitis C: an evolving concept entering the direct antiviral agents eraSavino Bruno, Alessandra Mangia
Seminars in Liver Disease|April 24, 2024
Adherence in Hepatitis C Virus Treatment: What We KnowSteven L Flamm, Alessandra Mangia
Cells|April 23, 2020
Noninvasive Diagnosis of NAFLD and NASHValeria Annarita Piazzolla, Alessandra Mangia
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 5, 2011
Chronic viral hepatitis: the histology reportMaria Guido, Alessandra Mangia, Gavino Faa, et al.
Pageof 16